Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Honglei Tu"'
Autor:
Zhuhao Wu, Zheng Ao, Hongwei Cai, Xiang Li, Bin Chen, Honglei Tu, Yijie Wang, Rongze Olivia Lu, Mingxia Gu, Liang Cheng, Xin Lu, Feng Guo
Publikováno v:
Journal of Nanobiotechnology, Vol 21, Iss 1, Pp 1-9 (2023)
Abstract Cancer immunotherapy shows promising potential for treating breast cancer. While patients may have heterogeneous treatment responses for adjuvant therapy, it is challenging to predict an individual patient’s response to cancer immunotherap
Externí odkaz:
https://doaj.org/article/681412411ac64529a06a805cee72a4a8
Autor:
Yanxia Jin, Qian Yang, Li Liang, Lu Ding, Yuxing Liang, Dongdong Zhang, Balu Wu, Tian Yang, Hailing Liu, Tingting Huang, Hui Shen, Honglei Tu, Yunbao Pan, Yongchang Wei, Yi Yang, Fuling Zhou
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 37, Iss 1, Pp 1-13 (2018)
Abstract Background The increase in the levels of reactive oxygen species (ROS) in acute myeloid leukemia (AML) patients has been previously described; thus, it is important to regulate ROS levels in AML. Methods Flow cytometry were used to assess th
Externí odkaz:
https://doaj.org/article/e44ab23873d3412ea7b297c1d3952715
Autor:
Zhang Dongdong, Yanxia Jin, Tian Yang, Qian Yang, Balu Wu, Yanling Chen, Ziyi Luo, Li Liang, Yunjiao Liu, Anjie Xu, Xiqin Tong, Can Can, Lu Ding, Honglei Tu, Yuxin Tan, Hongqiang Jiang, Xiaoyan Liu, Hui Shen, Li Liu, Yunbao Pan, Yongchang Wei, Fuling Zhou
Publikováno v:
Frontiers in Pharmacology, Vol 10 (2019)
Acute myeloid leukemia (AML) is a common type of hematological malignancy that can progress rapidly. AML has a poor prognosis and a high incidence of relapse due to therapeutic resistance. Azelaic acid (AZA), a small molecular compound is known to ex
Externí odkaz:
https://doaj.org/article/9a3ec296222e41cc970be2a11c0cbe28
Autor:
Can, Wang, Yan, Wen, Luo, Huang, Xin, Zhang, Yan, Luo, Deqing, Liu, Honglei, Tu, Xiaoyu, Li, Jiangdong, Sui, Yue, Xie, Jing, Li
Publikováno v:
In Heliyon 15 September 2024 10(17)
Autor:
Zhisu Liu, Li Teng, Yufeng Yuan, Wei Jing, Weijie Ma, Ganggang Wang, Haitao Wang, Xi Chen, Honglei Tu, Xiaoling Wu, Yongchang Wei, Chengjie Mei, Kunlei Wang, Xiang Jiang, Yiran Chen, Jinghua Li
Publikováno v:
Journal of Cellular Physiology. 235:7849-7862
Our previous studies have indicated that long noncoding RNA (lncRNA) SPRY4 intronic transcript 1 (SPRY4-IT1) was highly expressed in hepatocellular carcinoma (HCC). However, it still remained unclear how SPRY4-IT1 worked in tumorgenesis in HCC. In th
Autor:
Honglei Tu, Yanxia Jin, Lu Ding, Guolin Yuan, Hailing Liu, Xiqin Tong, Fuling Zhou, Yufeng Shang
Publikováno v:
OncoTargets and Therapy. 12:10587-10596
Objective Multiple myeloma (MM) patients with bone destruction are difficult to restore, so it is of great clinical significance to further explore the factors affecting MM bone destruction. Methods and results This study retrospectively analyzed 419
Autor:
Honglei Tu, Yufeng Shang, Yanxia Jin, Jinsong Hu, Fuling Zhou, Chenyao Lin, Hailing Liu, Longkai Zang, Xiqin Tong, Lu Ding
Publikováno v:
Hematological oncologyREFERENCES. 40(2)
This study aimed to evaluate the existing staging systems for multiple myeloma (MM) in the real world. From January 2010 to June 2019, we retrospectively analyzed 859 newly diagnosed MM patients from two institutions. Clinical data including laborato
Autor:
Jinsong Hu, Longkai Zang, Shang Yufeng, Fuling Zhou, Ding Lu, Honglei Tu, Hailing liu, Xiqin Tong, Chenyao Lin, Yanxia Jin
Purpose This study was to evaluate existing staging system of multiple myeloma (MM) in the real world. Methods We retrospectively analyzed 886 newly diagnosed MM from two institutions. Results The overall survival (OS) of eligible patients was 61.0 m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::04a2a8d84378fc0032087fb04a5434ec
https://doi.org/10.21203/rs.3.rs-305492/v1
https://doi.org/10.21203/rs.3.rs-305492/v1
Autor:
Yong Zhang, Qian Chu, Bitao Bu, Kun Xia, Fuling Zhou, Yongchang Wei, Li-Ya Hu, Yayun Cao, Yuan Chen, Honglei Tu, Min Zhang, Suqiong Ji
Publikováno v:
World Journal of Pediatrics
Background Severe cases of coronavirus disease 2019 (COVID-19) among pediatric patients are more common in children less than 1 year of age. Our aim is to address the underlying role of immunity and inflammation conditions among different age groups
Autor:
Tingting Huang, Dongdong Zhang, Balu Wu, Lulin Xu, Yin Liu, Fuling Zhou, Honglei Tu, Yiran Chen, Yuxin Tan, Hui Shen, Lu Ding, Li Liu, Yanxia Jin
Publikováno v:
Chemistrybiodiversity. 18(6)
Shengxuening (SXN) is a Chinese patent medicine with main ingredients (including chlorophyll derivatives and sodium iron chlorophyllin) extracted from silkworm excrement. SXN exhibited efficacy in clinical trials of renal anemia and iron deficiency a